Standardization and Quality Assurance of Radiation Therapy Volumes for Adults With High-Grade Gliomas

被引:7
|
作者
Fogh, Shannon [1 ]
Wahl, Michael [1 ]
Anwar, Mekhail [1 ]
Haas-Kogan, Daphne [1 ]
Clarke, Jennifer L. [2 ,3 ]
Sneed, Penny K. [1 ]
机构
[1] Univ Calif San Francisco, Sch Med, Dept Radiat Oncol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Sch Med, Dept Neurol Surg, San Francisco, CA 94143 USA
关键词
NEWLY-DIAGNOSED GLIOBLASTOMA; RADIOTHERAPY PLUS CONCOMITANT; PHASE-III TRIAL; MALIGNANT GLIOMA; CONFORMAL RADIOTHERAPY; ADJUVANT TEMOZOLOMIDE; CLINICAL-TRIAL; BRAIN-TUMORS; PATTERNS; MULTIFORME;
D O I
10.1016/j.semradonc.2014.06.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Standard treatment for Glioblastoma Multiforme (GBM) consists of a combination of chemotherapy and radiation therapy followed by adjuvant chemotherapy. While the optimal dose of radiation therapy has been established, significant variability in volume of tissue irradiated exists. In this article we review the current guidelines, patterns of care, patterns of failure, imaging advances and toxicity related to radiation therapy volumes in the treatment of GBM. (C) 2014 Published by Elsevier Inc.
引用
收藏
页码:259 / 264
页数:6
相关论文
共 50 条
  • [41] Evaluating changes in radiation treatment volumes from post-operative to same-day planning MRI in High-grade gliomas
    Champ, Colin E.
    Siglin, Joshua
    Mishra, Mark V.
    Shen, Xinglei
    Werner-Wasik, Maria
    Andrews, David W.
    Mayekar, Sonal U.
    Liu, Haisong
    Shi, Wenyin
    RADIATION ONCOLOGY, 2012, 7
  • [42] Adverse Events in Multimodal Treatment Therapies for High-Grade Gliomas
    Ngwenya, Laura B.
    Chiocca, E. Antonio
    WORLD NEUROSURGERY, 2011, 76 (1-2) : 67 - 68
  • [43] Biopsy versus resection in the management of high-grade gliomas in the elderly
    Zou, Yingjie
    Bai, Harrison Xiao
    Wang, Zhili
    Yang, Li
    NEURO-ONCOLOGY, 2015, 17 (06) : 901 - 903
  • [44] Therapy for Recurrent High-Grade Gliomas: Results of a Prospective Multicenter Study on Health-Related Quality of Life
    Stoeckelmaier, Linda
    Renovanz, Mirjam
    Koenig, Jochem
    Nickel, Katrin
    Hickmann, Anne-Katrin
    Mayer-Steinacker, Regine
    Nadji-Ohl, Minou
    Ganslandt, Oliver
    Bullinger, Lars
    Wirtz, Christian Rainer
    Coburger, Jan
    WORLD NEUROSURGERY, 2017, 102 : 383 - 399
  • [45] Feasibility and Therapeutic Potential of Peptide Receptor Radionuclide Therapy for High-Grade Gliomas
    Nemati, Reza
    Shooli, Hossein
    Rekabpour, Seyed Javad
    Ahmadzadehfar, Hojjat
    Jafari, Esmail
    Ravanbod, Mohammad Reza
    Amini, AbdolLatif
    Nemati, Ali
    Ghasemi, Mohammad
    Keshmiri, Saeid
    Dadgar, Habibollah
    Assadi, Majid
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (05) : 389 - 395
  • [46] Imaging modalities in high-grade gliomas: Pseudoprogression, recurrence, or necrosis?
    Caroline, I.
    Rosenthal, M. A.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2012, 19 (05) : 633 - 637
  • [47] 5-aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomas
    Mahmoudi, K.
    Garvey, K. L.
    Bouras, A.
    Cramer, G.
    Stepp, H.
    Raj, J. G. Jesu
    Bozec, D.
    Busch, T. M.
    Hadjipanayis, C. G.
    JOURNAL OF NEURO-ONCOLOGY, 2019, 141 (03) : 595 - 607
  • [48] Antiangiogenic therapy for high-grade glioma
    Khasraw, Mustafa
    Ameratunga, Malaka S.
    Grant, Robin
    Wheeler, Helen
    Pavlakis, Nick
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (09):
  • [49] Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas
    Boxerman, Jerrold L.
    Quarles, Chad C.
    Hu, Leland S.
    Erickson, Bradley J.
    Gerstner, Elizabeth R.
    Smits, Marion
    Kaufmann, Timothy J.
    Barboriak, Daniel P.
    Huang, Raymond H.
    Wick, Wolfgang
    Weller, Michael
    Galanis, Evanthia
    Kalpathy-Cramer, Jayashree
    Shankar, Lalitha
    Jacobs, Paula
    Chung, Caroline
    van den Bent, Martin J.
    Chang, Susan
    Al Yung, W. K.
    Cloughesy, Timothy F.
    Wen, Patrick Y.
    Gilbert, Mark R.
    Rosen, Bruce R.
    Ellingson, Benjamin M.
    Schmainda, Kathleen M.
    NEURO-ONCOLOGY, 2020, 22 (09) : 1262 - 1275
  • [50] Dendritic cell vaccines for high-grade gliomas
    Eagles, Matthew E.
    Nassiri, Farshad
    Badhiwala, Jetan H.
    Suppiah, Suganth
    Almenawer, Saleh A.
    Zadeh, Gelareh
    Aldape, Kenneth D.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 : 1299 - 1313